AstraZeneca PLC
1423.50
13-11月-24 11:24:56
15 分の遅延
株式
+15.50
+1.10%
本日の幅
1413.50 - 1446.00
ISIN
N/A
ソース
Cboe
-
NetDania - New 12 months High: AstraZeneca PLC
16 8 2024 03:17:04 提供 NetDania Notify
-
AstraZeneca (AZN) Imfinzi Combo Gets EU Nod for Uterine Cancer
15 8 2024 07:38:12 提供 NASDAQ Stocks
-
NetDania - New 12 months High: AstraZeneca PLC
15 8 2024 03:15:16 提供 NetDania Notify
-
NetDania - New 12 months High: AstraZeneca PLC
13 8 2024 03:19:30 提供 NetDania Notify
-
Ex-Dividend Reminder: Cencora, AstraZeneca and Wells Fargo
07 8 2024 10:27:01 提供 NASDAQ Stocks
-
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
04 8 2024 10:42:17 提供 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
29 7 2024 08:07:19 提供 NetDania Notify
-
AstraZeneca: Calquence Combo Enhances PFS In First-Line CLL In Phase III Trial
29 7 2024 03:38:02 提供 NASDAQ US Markets
-
AstraZeneca Reports ODAC's Review Of Imfinzi - Quick Facts
26 7 2024 03:05:05 提供 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
25 7 2024 03:15:03 提供 NetDania Notify
-
AstraZeneca Q2 Profit Rises, Lifts FY24 Outlook
25 7 2024 02:51:34 提供 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
23 7 2024 06:15:26 提供 NetDania Notify
-
NetDania - New 12 months High: AstraZeneca PLC
22 7 2024 08:17:57 提供 NetDania Notify
-
Interesting AZN Put And Call Options For August 23rd
03 7 2024 13:16:51 提供 NASDAQ US Markets
-
AstraZeneca: CHMP Recommends Lynparza And Imfinzi Combination For EU Approval In Endometrial Cancer
01 7 2024 03:09:21 提供 NASDAQ US Markets
-
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
28 6 2024 10:33:02 提供 NASDAQ Stocks
-
AstraZeneca: Imfinzi Trial Fails To Meet Endpoint In Early-stage Non-small Cell Lung Cancer
25 6 2024 03:08:02 提供 NASDAQ US Markets
-
AstraZeneca: Phase III Truqap Trial Plus Chemotherapy Fails To Meet Primary Goals In Breast Cancer
18 6 2024 03:15:21 提供 NASDAQ US Markets
-
AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial
16 6 2024 12:33:03 提供 NASDAQ US Markets
-
FDA Approves AstraZeneca's Farxiga For Pediatric Use In Type-2 Diabetes
12 6 2024 21:53:19 提供 NASDAQ US Markets